ClinicalTrials.gov
public full text
Public Domain
JAM3 as a Prognostic Biomarker in Muscle-Invasive Urothelial Carcinoma: Correlation With Therapeutic Response, and Survival Outcomes
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer#127572
- 3D Cancer Cell Model: A New Tool to More Accurately Evaluate the Biological Effect of Cold Plasma#239163
- Paclitaxel and TAK-228 in Urothelial Carcinoma#901000
- Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer#884805
- An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry#994148
Record · ID 290997
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive